Orcosa Inc.
Ewing, NJ · Founded 2020 · CIK 0001852165 · Medtech
next-generation drug delivery technology platform
orcosa.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $49M
- 3 Form D · Jan 2025
- 21 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 2 granted · 38 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $37,925,000 | |
| Private capital raised | Form D · SEC | $3,529,800 | |
| Private capital raised | Form D · SEC | $7,275,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1426 | DIASCOPIC, LLC | — | — |
| 1427 | BUY TIME MEDICAL INC | — | — |
| 1428 | Vifant LLC | — | — |
| 1429 | Orcosa Inc. | — | $49M |
| 1430 | BH2 Innovations Inc. | — | $275K |
| 1431 | EKO Devices, Inc. | — | — |
| 1432 | Pulmokine, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Vincent MiletoDirector · Executive Officer
- Robert PollaroDirector · Executive Officer
- Bryan RidallDirector · Executive Officer
- Mark RidallDirector · Executive Officer
Patents
- Packaging For Rapidly Infusing Compositionapplication
- Packaging For Rapidly Infusing Compositiongranted
- Methods Of Treating Autoimmune Or Inflammatory Conditions With Cannabidiol Or Its Derivatives/analogsapplication
- Cannabinoids In The Treatment Of Autism Spectrum Disorderapplication
- Rapidly Infusing Compositions For Oral Mucosal Delivery And Methodsapplication
- Rapidly Infusing Compositions With Supplements And Treatment Methodsapplication
- Use Of Cannabinoids In The Treatment Of Tourette Syndrome And Tic Disordersapplication
- Improved Use Of Cannabinoids In The Treatment Of Epilepsyapplication
- Improved Use Of Cannabinoids In The Treatment Of Alzheimer's Diseaseapplication
- Rapidly Infusing Cannabinoid Compositions, Processes Of Manufacture, And Methods Of Useapplication
- Rapidly Infusing Compositions With Methotrexate And Treatment Methodsapplication
- RAPIDLY DISINTERGRATING COMPOSITIONS AND METHODS (Nicotine)application
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.